LODE Comstock Inc.
Industrial Organic Chemicals · NYSE · SEC CIK 1120970 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-52.2%
TTM net income YoY7.1%
TTM EPS YoY—
Revenue 3-yr CAGR15.7%
Net income 3-yr CAGR—
Margins
Gross margin-151.8%
Operating margin-3,535.2%
Net margin-3,680.5%
FCF margin—
EBITDA margin-3,173.9%
Returns
ROE-38.2%
ROA-27.2%
ROIC (approx.)-40.2%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets22.9%
Debt / equity0.00x
Current ratio3.31x
Interest coverage-67.29x
Cash quality & payout
Operating cash flow / net income0.64x
Accruals ratio-9.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.55M | $3.02M | $1.27M | $178,150 | $862,165 |
| Cost of revenue | $2.63M | $451,938 | $0 | $0 | $272,082 |
| Gross profit | -$1.07M | $2.56M | $1.27M | $178,150 | $590,083 |
| R&D expense | $12.32M | $19.10M | $6.12M | $7.02M | $414,751 |
| SG&A expense | $20.67M | $12.70M | $12.59M | $10.24M | $5.55M |
| Operating income | -$38.15M | -$39.67M | -$12.60M | -$19.36M | -$6.41M |
| Interest expense | $1.93M | $2.97M | $1.65M | $1.65M | $168,881 |
| Pretax income | $43.08M | $53.32M | — | -$46.74M | -$30.33M |
| Income tax | $0 | $0 | $0 | $0 | -$5.75M |
| Net income | -$43.08M | -$53.32M | $9.16M | -$46.74M | -$24.58M |
| EBITDA | -$34.31M | -$37.42M | -$10.13M | -$16.03M | -$5.37M |
| EPS (basic) | -1.17 | -3.21 | 0.87 | -0.62 | -0.49 |
| EPS (diluted) | -1.17 | -3.21 | 0.87 | -0.62 | -0.49 |
| Weighted avg. shares (diluted) | 36.71M | 16.61M | 10.52M | 74.46M | 50.42M |
| Banking | |||||
| Deposits | — | — | $410,100 | $422,603 | — |
| Balance sheet | |||||
| Cash & equivalents | $16.95M | $954,271 | $3.79M | $2.52M | $5.91M |
| Short-term investments | — | $0 | $18.91M | $0 | — |
| Receivables | $1.29M | $2.42M | $26,364 | $4.99M | — |
| Current assets | $20.66M | $12.56M | $23.18M | $30.77M | $13.83M |
| PP&E, net | $29.89M | $8.61M | $15.20M | $13.47M | $14.56M |
| Goodwill | $1.51M | $0 | — | $0 | $12.79M |
| Intangibles | $26.45M | $5.86M | $15.87M | $17.66M | $23.18M |
| Total assets | $169.60M | $91.31M | $106.47M | $100.05M | $126.95M |
| Current liabilities | $10.02M | $8.11M | $14.84M | $31.63M | $23.91M |
| Short-term debt | $0 | $97,593 | $4.50M | $1.80M | $0 |
| Long-term debt | $0 | $8.39M | $5.36M | $6.12M | $4.49M |
| Total debt | $0 | $8.49M | $9.85M | $7.92M | $4.49M |
| Total liabilities | $58.70M | $31.54M | $28.19M | $43.69M | $33.98M |
| Shareholders' equity | $107.58M | $59.77M | $78.28M | $53.60M | $89.57M |
| Net debt | -$16.95M | $7.53M | $6.07M | $5.40M | -$1.43M |
| Shares outstanding | 51.85M | 23.51M | 11.79M | 91.44M | 71.21M |
| Cash flow statement | |||||
| Operating cash flow | -$24.39M | -$13.94M | -$13.63M | -$12.11M | -$7.49M |
| Capital expenditure | — | — | $1.82M | $1.01M | $78,467 |
| Free cash flow | — | — | -$15.44M | -$13.12M | -$7.57M |
| Investing cash flow | -$21.98M | -$6.48M | $3.63M | -$3.73M | -$16.10M |
| Financing cash flow | $62.36M | $17.59M | $11.26M | $12.45M | $27.07M |
| Depreciation & amortization | $3.84M | $2.24M | $2.48M | $3.33M | $1.03M |
| Stock-based compensation | $0 | $41,799 | -$2,256 | $481,997 | $463,986 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.